Clinical Trials Directory

Trials / Unknown

UnknownNCT05660499

Impact of the Development of Pediatric Palliative Care

Assessment of the Presence of Symptoms of End-of-life Discomfort and Their Management in Children With a Primary Brain Tumor in the Grand Est Region. Impact of the Development of Pediatric Palliative Care

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
1 Year – 17 Years
Healthy volunteers
Not accepted

Summary

Despite medical advances, cancer remains the leading cause of death by disease in children. Brain tumors are the second most common cause of cancer in children after leukemia, representing 25% of pediatric cancers. The overall survival rate is about 50% with extremes ranging from less than 5% to more than 90% depending on the histological type of brain tumor. The end of life of children with a brain tumor is marked by the possibility of discomfort symptoms, painful or not, and by a progressive neurological deterioration, which makes the management of these children complex for both families and health professionals. Over the last decade, the concept of palliative care has been increasingly integrated into pediatric onco-hematology services with the primary objective of better symptom control in a global approach to the child and his or her family in order to aim at a better quality of life.

Detailed description

The main objective of the study is to compare the occurrence and management of end-of-life symptoms in children who died of a primary brain tumor over 2 periods, in 2009 - 2010 and in 2019 - 2020, followed in the Pediatric Oncology departments of Strasbourg, Besançon, Dijon, Nancy and Reims.

Conditions

Timeline

Start date
2021-02-15
Primary completion
2023-12-01
Completion
2023-12-31
First posted
2022-12-21
Last updated
2023-12-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05660499. Inclusion in this directory is not an endorsement.